Bethany Mundy-Bosse

Historically, much of the gender gap in earnings could be explained by differences in education and occupational choices. However, this year’s economic sciences laureate Claudia Goldin has shown that the bulk of this earnings difference is now between men and women in the same occupation, and that it largely arises with the birth of the first child. #NobelPrize

Wonderful last day of NK2023 in Oslo. ⁦@SNI_NKMeeting⁩ Already looking forward to the next one, NK2025 down under!

Now accepting applications for the Immunology and Immunotherapeutics PhD Graduate Program (I2GP) @OhioStateMed. Come join our growing community of Immunologists and perform leading edge research in top level facilities! @OhioStatePIIO @OSUCCC_James Apply: gpadmissions.osu.edu/programs/progr…

Abstract book access will be distributed to #NK2023 participants today! We are also launching a digital message board for posting of job adverts etc, send us an e-mail to post nk2023.org

Super excited to have @LesinskiLab back at OSU for a @OhioStatePIIO talk! Looking forward to learning more about the cutting edge science being done @WinshipAtEmory

Great seminar today on the role of persistent AP-1 activation in #NKcell exhaustion programming in #AML by Erin Jeremy, graduate student mentored by Dr. Bethany @MundyBosse and Dr. @KarilynLarkin.

@LordoMatt So proud of my first PhD student, Dr. Matthew Lordo, congrats!!!

Matthew Lordo, PhD Five years after embarking on this crazy journey in the lab, I successfully defended my dissertation this morning in front of my committee and many of the friends and family who have supported me over the years. 🥂🍾🥳🎓 #phdone #phd #gradschool

Abstract submission for #NK2023 opens Monday March 20th @ nk2023.org. Time to get your last experiments done! Deadline for submission May 3. Look forward to lots of new exciting data in Oslo in September!! 🤩🤩

Deciphering the localization and trajectory of human natural killer cell development by Everardo Hegewisch-Solloa ift.tt/Y42zRiw

Our high risk CCUS study to prevent progression to MDS/AML is enrolling! Based on a large body of evidence,we target the Inflammasome via IL-1b.First trial of its kind, led by HALT program .See details👇🏾.DM me for questions! clinicaltrials.gov/ct2/show/NCT05… @OSUCCC_James @OSUHematology

7 days left before we open up for the registration for #NK2023! You don't want to miss out on this meeting, fantastic line-up of speakers and a great program awaits you in September! 😁 nk2023.org

Bearing a grudge—How human NK cells remember past insults @mace_em commentary on @RomagnaniLab paper science.org/doi/10.1126/sc…

New paper out this week from talented @OHSUKnight graduate student @BreannaManiaci_! (1/x) haematologica.org/haematologica/…

Hot off the presses, some collaborative work from our group describes a human liver type ILC1 (Lin-CD49a+CD94+CD200R1+TBET+NKp80-EOMES-) enriched in the setting of cirrhosis that could also be found in tonsil and intestinal tissues. #ilc #immunology

@LordoMatt @theLarryOSU Hey that’s what happens when you have a great lab-trainees don’t want to leave 😂

@theLarryOSU 😂😂😂😂😂

Last conference poster session of grad school ✅. Next stop, PhD defense! #ash22 #gradschool

TRTH mentorship (and friendship 💕) still going strong after 5 years! @ASH_hematology @EHA_Hematology #ASH2022 @MundyBosse @kean_leslie

Selective expansion of adaptive NK cells from “superdonors”. This paper describes the pre-clinical evaluation, scale-up and GMP transfer activities paving the way for our next NK cell therapy trial. Team effort led by @AlvaroHaroun and @ebba_sohlberg with lots of collaborators.

Writing a great abstract can be tricky! This writing template by @Nature is super helpful 👉